1. Role of Cytomorphology in the Era of Liquid Biopsy
    Eduardo Clery et al, 2019, Acta Cytologica CrossRef
  2. mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagy
    Yan Zheng et al, 2017, Journal of Nanobiotechnology CrossRef
  3. Integration of liquid biopsy and pharmacogenomics for precision therapy of EGFR mutant and resistant lung cancers
    Jill Kolesar et al, 2022, Molecular Cancer CrossRef
  4. Liquid Biopsy for Small Cell Lung Cancer either De Novo or Transformed: Systematic Review of Different Applications and Meta-Analysis
    Elio Gregory Pizzutilo et al, 2021, Cancers CrossRef
  5. Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung Cancer
    Fiorella Calabrese et al, 2022, International Journal of Molecular Sciences CrossRef
  6. Pathological transition as the arising mechanism for drug resistance in lung cancer
    Yueqing Chen et al, 2019, Cancer Communications CrossRef
  7. Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy
    R. Minari et al, 2018, Lung Cancer CrossRef
  8. Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy
    Marzia Del Re et al, 2019, International Journal of Molecular Sciences CrossRef
  9. Sequential occurrence of small cell and non-small lung cancer in a male patient: Is it a transformation?
    Ahsan Wahab et al, 2017, Cancer Biology & Therapy CrossRef
  10. Successful sequential treatment of refractory tumors caused by small cell carcinoma transformation and EGFR-T790M mutation diagnosed by repeated genetic testing in a patient with lung adenocarcinoma harboring epidermal growth factor receptor mutations: A case report
    Naoya Nishioka et al, 2018, Respiratory Medicine Case Reports CrossRef
  11. Intrapatient Molecular and Histologic Heterogeneity After First-generation or Second-generation TKI Therapy of NSCLC Patients
    Daniela Iacono et al, 2019, American Journal of Clinical Oncology CrossRef
  12. Histological transformation after acquired resistance to epidermal growth factor tyrosine kinase inhibitors
    Yi Shao et al, 2018, International Journal of Clinical Oncology CrossRef
  13. Small Cell Transformation and T790M Mutation as Coresistance Mechanisms for First-line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy Failure
    Chee Shee-Chai et al, 2017, Journal of Thoracic Oncology CrossRef